Water-soluble substituted chitosan derivatives as technology platform for inhalation delivery of siRNA
Despite research efforts full potential of siRNA-based therapeutics has not yet been fully realized due to a need for suitable, effective delivery formulations. Here, we examine a potential of a new class of water-soluble chitosans as siRNA platform for pulmonary delivery. The system is based on pip...
Saved in:
Main Authors: | Victoria Capel (Author), Driton Vllasaliu (Author), Peter Watts (Author), Philip A. Clarke (Author), Dominic Luxton (Author), Anna M. Grabowska (Author), Giuseppe Mantovani (Author), Snjezana Stolnik (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
by: Borja Ballarín-González, et al.
Published: (2013) -
Chitosan and Its Structural Modifications for siRNA Delivery
by: Mona Y. Al-Absi, et al.
Published: (2023) -
Chitosan Oleate Coated PLGA Nanoparticles as siRNA Drug Delivery System
by: Dalila Miele, et al.
Published: (2021) -
Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA
by: Elzeny H, et al.
Published: (2017) -
Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application
by: Yulin Fan, et al.
Published: (2022)